Literature DB >> 33456932

Drug reactions with eosinophilia and systemic symptoms.

B Scrace1, A Fityan2, C Bigham1.   

Abstract

Entities:  

Year:  2020        PMID： 33456932      PMCID： PMC7808006          DOI： 10.1016/j.bjae.2019.11.001

Source DB:  PubMed          Journal:  BJA Educ        ISSN： 2058-5349


× No keyword cloud information.
  22 in total

Review 1.  Physiopathology and treatment of severe drug eruptions.

Authors:  N Bachot; J C Roujeau
Journal:  Curr Opin Allergy Clin Immunol       Date:  2001-08

Review 2.  Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome.

Authors:  Yoko Kano; Tadashi Ishida; Kazuhisa Hirahara; Tetsuo Shiohara
Journal:  Med Clin North Am       Date:  2010-07       Impact factor: 5.456

Review 3.  The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.

Authors:  Yoko Kano; Tetsuo Shiohara
Journal:  Immunol Allergy Clin North Am       Date:  2009-08       Impact factor: 3.479

4.  High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome.

Authors:  Yukiko Kito; Taisuke Ito; Yoshiki Tokura; Hideo Hashizume
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

5.  Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.

Authors:  N Ortonne; L Valeyrie-Allanore; S Bastuji-Garin; J Wechsler; S de Feraudy; T-A Duong; M-H Delfau-Larue; O Chosidow; P Wolkenstein; J-C Roujeau
Journal:  Br J Dermatol       Date:  2015-04-16       Impact factor: 9.302

6.  Fulminant myocarditis as a late sequela of DRESS: two cases.

Authors:  Greg P Bourgeois; Jennifer A Cafardi; Vlada Groysman; Salpy V Pamboukian; James K Kirklin; Aleodor A Andea; Lauren C Hughey
Journal:  J Am Acad Dermatol       Date:  2011-10       Impact factor: 11.527

7.  Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients.

Authors:  C Hotz; L Valeyrie-Allanore; C Haddad; S Bouvresse; N Ortonne; T A Duong; S Ingen-Housz-Oro; J C Roujeau; P Wolkenstein; O Chosidow
Journal:  Br J Dermatol       Date:  2013-12       Impact factor: 9.302

8.  Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases.

Authors:  Yi-Chun Chen; Hsien-Ching Chiu; Chia-Yu Chu
Journal:  Arch Dermatol       Date:  2010-08-16

9.  Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.

Authors:  S Walsh; S Diaz-Cano; E Higgins; R Morris-Jones; S Bashir; W Bernal; D Creamer
Journal:  Br J Dermatol       Date:  2013-02       Impact factor: 9.302

Review 10.  Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update.

Authors:  S Tas; T Simonart
Journal:  Dermatology       Date:  2003       Impact factor: 5.366
View more
  1 in total

Review 1.  Life-threatening skin conditions presenting to critical care.

Authors:  M Bromley; S Marsh; A Layton
Journal:  BJA Educ       Date:  2021-07-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.